Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis.
Srilekha PanguluriPraveen GundaLaurie DebonnettKamal A HamedPublished in: Clinical drug investigation (2018)
TIP is likely to be a more cost-effective treatment than TIS, and therefore may reduce the economic burden of CF.